Caulophyllogenin

TargetMol
Product Code: TAR-TN1475
Supplier: TargetMol
CodeSizePrice
TAR-TN1475-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1475-1mg1mg£161.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1475-5mg5mg£285.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1475-10mg10mg£385.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1475-25mg25mg£597.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Caulophyllogenin is a partial PPARγ agonist (EC50?=?12.6?μM) derived from the stem bark of Kalopanax pictus (Araliaceae). Caulophyllogenin inhibits pro-inflammatory cytokine secretion and can be used in studies about the prevention and treatment of inflammatory diseases, type-2 diabetes, obesity and metabolic syndrome.
CAS:
52936-64-8
Formula:
C30H48O5
Molecular Weight:
488.709
Pathway:
Metabolism; DNA Damage/DNA Repair; Apoptosis; Immunology/Inflammation
Purity:
0.9856
SMILES:
[H][C@@]12CC(C)(C)CC[C@@]1([C@H](O)C[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)[C@@](C)(CO)[C@]3([H])CC[C@@]12C)C(O)=O
Target:
IL Receptor; TNF; PPAR; Immunology/Inflammation related

References

Montanari R, et, al. Screening of saponins and sapogenins from Medicago species as potential PPAR? agonists and X-ray structure of the complex PPAR?/caulophyllogenin. Sci Rep. 2016 Jun 10; 6:27658. Zhang Y, et, al. Studies on cytotoxic triterpene saponins from the leaves of Aralia elata. Food Chem. 2013 May 1;138(1):208-13. Quang TH, et al. Inhibitory effects of oleanane-type triterpenes and saponins from the stem bark of Kalopanax pictus on LPS-stimulated pro-inflammatory cytokine production in bone marrow-derived dendritic cells. Arch Pharm Res. 2013 Mar;36(3):327-34.